NPs Basic Information

Name
Isovaleric acid
Molecular Formula C5H10O2
IUPAC Name*
3-methylbutanoic acid
SMILES
CC(C)CC(=O)O
InChI
InChI=1S/C5H10O2/c1-4(2)3-5(6)7/h4H,3H2,1-2H3,(H,6,7)
InChIKey
GWYFCOCPABKNJV-UHFFFAOYSA-N
Synonyms
ISOVALERIC ACID; 3-Methylbutanoic acid; 503-74-2; 3-Methylbutyric acid; Isopentanoic acid; Delphinic acid; Butanoic acid, 3-methyl-; Isopropylacetic acid; Isovalerianic acid; Isobutylformic acid; 3-Methylbutyrate; beta-Methylbutyric acid; Isovalerianic; Acetic acid, isopropyl-; Butyric acid, 3-methyl-; 3-methyl-butanoic acid; isovalerate; Kyselina isovalerova; 3-methyl butyric acid; 3-methyl-butyric acid; FEMA No. 3102; 3-methyl-n-butyric acid; Isovaleriansaeure; .beta.-Methylbutyric acid; MFCD00002726; NSC 62783; 3-Methylbuttersaeure; b-Methylbutyric acid; 3,4-Diisovaleryl adrenaline; CHEBI:28484; 1BR7X184L5; Butanoic acid, 3-methyl-, (R)-; isopropylacetate; NSC-62783; IVA; Isobutyl formic acid; Isovaleric acid (natural); FEMA Number: 3102; Kyselina isovalerova [Czech]; methyl butanoic acid; HSDB 629; EINECS 207-975-3; METHYLBUTANOIC ACID; BRN 1098522; UNII-1BR7X184L5; AI3-24132; b-Methylbutyrate; iso-valeric acid; 3-Methylbutanoicacid; DELPHINIC-ACID; iso-C4H9COOH; Isovaleric acid, 99%; DSSTox_CID_9182; bmse000373; EC 207-975-3; DSSTox_RID_78698; DSSTox_GSID_29182; SCHEMBL43436; ISOVALERIC ACID [MI]; 4-02-00-00895 (Beilstein Handbook Reference); ISOVALERIC ACID [FCC]; NATURAL ISOVALERIC ACID; Isopropyl Acetic Acid, natural; ISOVALERIC ACID [FHFI]; ISOVALERIC ACID [HSDB]; CHEMBL568737; WLN: QV1Y1&1; DTXSID5029182; ISOVALERIC ACID [MART.]; ISOVALERIC ACID [WHO-DD]; ZINC388188; AMY40214; BCP32116; NSC62783; STR08356; Isovaleric acid, analytical standard; Tox21_201604; BBL027399; LMFA01020181; s6287; STL146358; AKOS000119861; Isovaleric acid, >=99%, FCC, FG; CS-W013696; DB03750; HY-W012980; 3-Methylbutyric acid: isopropyl-Acetate; Isovaleric acid sodium salt (Salt/Mix); Isovaleric acid, natural, >=98%, FG; NCGC00249082-01; NCGC00259153-01; 35915-22-1; CAS-503-74-2; 3-Methylbutyric acid: isopropyl-Acetic acid; FT-0627533; M0182; EN300-19718; C08262; D78213; Q415536; J-522594; F2191-0067; Z104474910; 3-Methylbutanoic acid;3-Methylbutyric acid;Isopentanoic acid; 92634-50-9
CAS 503-74-2
PubChem CID 10430
ChEMBL ID CHEMBL568737
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Fatty Acyls
        • Subclass: Fatty acids and conjugate
          • Direct Parent: Methyl-branched fatty aci

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 102.13 ALogp: 1.2
HBD: 1 HBA: 2
Rotatable Bonds: 2 Lipinski's rule of five: Accepted
Polar Surface Area: 37.3 Aromatic Rings: 0
Heavy Atoms: 7 QED Weighted: 0.574

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.685 MDCK Permeability: 0.00009820
Pgp-inhibitor: 0.001 Pgp-substrate: 0.001
Human Intestinal Absorption (HIA): 0.006 20% Bioavailability (F20%): 0.002
30% Bioavailability (F30%): 0.004

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.946 Plasma Protein Binding (PPB): 40.33%
Volume Distribution (VD): 0.257 Fu: 64.67%

ADMET: Metabolism

CYP1A2-inhibitor: 0.03 CYP1A2-substrate: 0.095
CYP2C19-inhibitor: 0.021 CYP2C19-substrate: 0.472
CYP2C9-inhibitor: 0.01 CYP2C9-substrate: 0.961
CYP2D6-inhibitor: 0.011 CYP2D6-substrate: 0.145
CYP3A4-inhibitor: 0.007 CYP3A4-substrate: 0.078

ADMET: Excretion

Clearance (CL): 8.96 Half-life (T1/2): 0.807

ADMET: Toxicity

hERG Blockers: 0.006 Human Hepatotoxicity (H-HT): 0.132
Drug-inuced Liver Injury (DILI): 0.286 AMES Toxicity: 0.009
Rat Oral Acute Toxicity: 0.32 Maximum Recommended Daily Dose: 0.016
Skin Sensitization: 0.292 Carcinogencity: 0.076
Eye Corrosion: 0.979 Eye Irritation: 0.993
Respiratory Toxicity: 0.049
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000031 0.545 D00WUF 0.500
ENC000376 0.545 D09PUL 0.364
ENC000237 0.545 D08QGD 0.348
ENC000445 0.542 D0M8AB 0.333
ENC000149 0.500 D02KJX 0.321
ENC000685 0.429 D04CRL 0.316
ENC000241 0.429 D0A8CJ 0.313
ENC000289 0.417 D00ZOF 0.292
ENC000147 0.400 D0ZK8H 0.276
ENC000058 0.400 D08HZC 0.267
*Note: the compound similarity was calculated by RDKIT.